Combination therapy with protein kinase inhibitor H89 and Tetrandrine elicits enhanced synergistic antitumor efficacy.

Yu M, Liu T, Chen Y, Li Y, Li W
J Exp Clin Cancer Res. 2018 Jun 4;37(1):114. doi: 10.1186/s13046-018-0779-2. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.